Literature DB >> 6310672

Familial benign hypercalcaemia. Study of a large family.

F H Menko, O L Bijvoet, J L Fronen, L M Sandler, S Adami, J L O'Riordan, W Schopman, G Heynen.   

Abstract

Twenty-seven hypercalcaemic subjects were identified in three generations of a family. There were no clinical complications of chronic hypercalcaemia, but five had had parathyroid surgery which was unsuccessful in four. Twenty of the twenty-seven subjects were compared with twenty-four normocalcaemic controls from the same family and the findings were also compared with those from forty patients with surgically proven primary hyperparathyroidism. The relation between the serum and urinary calcium levels was studied by means of an oral calcium loading test. The ratio of calcium clearance to creatinine clearance was normal in this family (but elevated in the patients with primary hyperparathyroidism) and the concentration of parathyroid hormone was normal, as was the total urinary excretion of cyclic AMP. Thus, there was no evidence of either suppressed or increased parathyroid activity in this familial condition. Basal urinary calcium excretion was normal under steady-state conditions indicating that the hypercalcaemia could not be attributed to either increased bone resorption or increased calcium absorption from the gut. In accordance with this, the serum levels of 1,25-dihydroxycholecalciferol were normal. The hypercalcaemia in this condition can be accounted for in full by an increase in renal tubular reabsorption of calcium, and thus differs from that of primary hyperparathyroidism in which there is increased production of calcium from gut and/or bone as well as an increase in renal tubular reabsorption of calcium. Although the serum phosphate and renal tubular reabsorption of phosphate were both low in patients with familial benign hypercalcaemia, they were not as low as in patients with the same degree of hypercalcaemia due to primary hyperparathyroidism. The changes in phosphate transport in familial benign hypercalcaemia could be explained as a secondary effect of the increased filtered load of calcium in the kidney. The tendency towards hypermagnesaemia in our patients, which contrasts with a tendency towards hypomagnesaemia in primary hyperparathyroidism, could also be explained as a secondary effect of the abnormality of renal tubular reabsorption of calcium. Increased renal tubular calcium reabsorption and persistent normal functioning of the parathyroid glands in the face of hypercalcaemia remain the sole definite abnormalities of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310672

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

Review 1.  Familial hypocalciuric hypercalcemia.

Authors:  D A Heath
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 3.  The calcium-sensing receptor in bone--mechanistic and therapeutic insights.

Authors:  David Goltzman; Geoffrey N Hendy
Journal:  Nat Rev Endocrinol       Date:  2015-03-10       Impact factor: 43.330

4.  Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.

Authors:  Y H Chou; M R Pollak; M L Brandi; G Toss; H Arnqvist; A B Atkinson; S E Papapoulos; S Marx; E M Brown; J G Seidman
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

Review 5.  Familial benign hypercalcemia--from clinical description to molecular genetics.

Authors:  H Heath
Journal:  West J Med       Date:  1994-06

6.  Familial benign hypercalcaemia (FBH; McK. No. 14598, 1983): linkage studies in a large Dutch family.

Authors:  F H Menko; O L Bijvoet; P Meera Khan; L E Nijenhuis; E von Loghem; I Schreuder; L F Bernini; J C Pronk; K Madan; L N Went
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.

Authors:  M R Pollak; Y H Chou; S J Marx; B Steinmann; D E Cole; M L Brandi; S E Papapoulos; F H Menko; G N Hendy; E M Brown
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH.

Authors:  D Trump; M P Whyte; C Wooding; J T Pang; S H Pearce; D B Kocher; R V Thakker
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

9.  Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo.

Authors:  Neva J Fudge; Christopher S Kovacs
Journal:  BMC Physiol       Date:  2004-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.